The pharmaceutical industry is seeing a shift toward personalized medicines, and it’s evolving to deliver this via some exciting new tools.

A prime example is the recent announcement of ATMPS’ Hataali blockchain platform being successfully tested with the University Hospitals Birmingham NHS Foundation Trust’s system interface; denoting it as the world’s first blockchain solution for Advanced Therapeutic Medicinal Products (ATMP).

Taking the digital shift in a different direction, within the life sciences industry TraceLink has now managed to leverage cloud technologies to create the world’s largest network of pharmaceutical supply chain partners and allow them to connect seamlessly.

Add the fact that scientists from Rice University Bioengineering have used deep-learning methods to develop their Metabolite Translator, a computer system that can predict what the in-vivo metabolites of a drug could be in order to identify its potential toxicity, and it’s clear to see that times are changing!

In an industry that is notoriously non-digital, these bold developments are inevitably the foundation blocks of a new and exciting chapter in our history.

Follow us on LinkedIn to stay abreast of all the latest news and events.

Additional News

  • 18 July 2023

    Challenges of a large-scale study of breast cancer

    Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.

  • 29 June 2023

    EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.

    After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.

  • 22 June 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency